Diagnosis and management of cerebral venous thrombosis: a Scientific Statement from the American Heart Association
Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable
populations include young individuals, women of reproductive age, and patients with a …
populations include young individuals, women of reproductive age, and patients with a …
Cerebral venous thrombosis: an update
JM Ferro, D Aguiar de Sousa - Current neurology and neuroscience …, 2019 - Springer
Abstract Purpose of Review The purpose of this update is to summarize the recent advances
on the management of cerebral venous thrombosis (CVT). Recent Findings There is a trend …
on the management of cerebral venous thrombosis (CVT). Recent Findings There is a trend …
Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19
DISCUSSION The estimated relative frequency and 99% CI estimates for CVST for
AstraZeneca and J&J vaccines based on the available reported events are markedly lower …
AstraZeneca and J&J vaccines based on the available reported events are markedly lower …
Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation
Background and Purpose—The hypothesis that venous recanalization prevents progression
of venous infarction is not established in patients with cerebral venous thrombosis (CVT) …
of venous infarction is not established in patients with cerebral venous thrombosis (CVT) …
Endovascular treatment of intracranial vein and venous sinus thrombosis—a systematic review
P Buecke, V Hellstern, A Cimpoca, JE Cohen… - Journal of clinical …, 2022 - mdpi.com
Background: Cerebral venous sinus or vein thromboses (SVT) are treated with heparin
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
Venous stroke–a stroke subtype that should not be ignored
Y Zhou, H Jiang, H Wei, L Liu, C Zhou, X Ji - Frontiers in Neurology, 2022 - frontiersin.org
Based on the etiology, stroke can be classified into ischemic or hemorrhagic subtypes,
which ranks second among the leading causes of death. Stroke is caused not only by …
which ranks second among the leading causes of death. Stroke is caused not only by …
Safety and clinical outcomes in endovascular treatment for symptomatic cerebral venous thrombosis: a single-center experience with meta-analysis
The role of mechanical thrombectomy (MT) in cerebral venous sinus thrombosis (CVT) is
ambiguous. This study aims to share our experience with MT in CVT, supplemented by a …
ambiguous. This study aims to share our experience with MT in CVT, supplemented by a …
Mechanical thrombectomy in cerebral venous sinus thrombosis: reports of a retrospective single-center study
F Jedi, G Dethlefs, TK Hauser, F Hennersdorf… - Journal of Clinical …, 2022 - mdpi.com
Current standard care for acute cerebral venous sinus thrombosis (CVST) includes either
intravenous heparin or subcutaneous low-molecular-weight heparin, but patients with …
intravenous heparin or subcutaneous low-molecular-weight heparin, but patients with …
Diagnosis and treatment of cerebral venous thrombosis
AL Liberman - CONTINUUM: Lifelong Learning in Neurology, 2023 - journals.lww.com
OBJECTIVE Cerebral venous thrombosis (CVT), thrombosis of the dural sinus, cerebral
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …
Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases
Background Administrative data are frequently used in stroke research. Ensuring accurate
identification of patients who had an ischaemic stroke, and those receiving thrombolysis and …
identification of patients who had an ischaemic stroke, and those receiving thrombolysis and …